Cookie Consent by
genekam logo
  • usa
    • german
    • russia
    • china
Duissernstr. 65a · 47058 Duisburg · Germany
Tel. +49 203 / 555 858 -31 / 32 / 33 · Fax: +49 203 / 35 82 99
Mission 2024:

Genekam making ready
for Nasdaq IPO 2024

Latest News:

Genekam to attend BIO CEO & Investor Conference
February 26-27, 2024 | New York


    A number of Genekam products are registered with EUDAMED
    A step towards meeting the lastest IVDR requirements

  • LSX World conference

    Genekam is to attend LSX World conference 29-30 April, 2024, Business Design Center, London, UK

  • MEDICA 2024

    Visit us on Medica Duesseldorf, 11.-14. November 2024


We are going to develop a distributor network throughout the world, hence in future, our all offers and quotations are going to be through these distributors. If you are interested in this, kindly send us your profile and inquiry.

You are using this contact form to send us your data. Please read our guidelines for General data protection regulations.

General data protection regulations: Genekam Biotechnology AG stores data of companies, institutes, organisations and its employees (Name, contact adress, email and telephone number), which express interest in Genekam business activities like products and services. This data is used to maintain our business relations with interested parties. We don't redistribute or share this data to any other company in any form. We use this data only for sending our information letter through email. If you don't want to maintain business relationsship any more, you can send at any time an email to the following adress: to oppose it; i.e. your request to remove your data. With the removal of your data, you cannot maintain the business relations with Genekam Biotechnology AG.

*) Mandatory fields